Connor, Clark & Lunn Investment Management Ltd. Q3 2016 Filing

Filed November 15, 2016

Portfolio Value

$14.3B

Holdings

826

Report Date

Q3 2016

Filing Type

13F-HR

All Holdings (826 positions)

StockValue
Calithera Biosciences Inc
$46K
Bioscrip Inc
$44K
Anthera Pharmaceuticals Inc.
$43K
ModusLink Global Solutions Inc
$43K
TTPHEURTetraphase Pharmaceuticals Inc.
$42K
Navios Maritime Acquisition
$40K
Aviragen Therapeutics Inc
$40K
MCHXMarchex Inc
$38K
Vical Inc
$36K
AMZNAmazon.Com Inc
$36K
Rubicon Technology Inc
$35K
Gulfmark Offshore Inc
$34K
Pain Therapeutics Inc
$31K
Aptevo Therapeutics Inc
$29K
Protalix Biotherapeutics
$29K
Bebe Stores Inc.
$29K
Pronai Therapeutics Inc
$27K
Central European Enterprises Ltd.
$25K
Christopher & Banks Corp
$24K
BKNGPriceline Group Inc
$22K
UTIUniversal Technical Inst
$18K
aveo pharmaceuticals inc
$16K
The Female Health Company
$15K
GOOGLAlphabet Inc - CL A
$9K
Pendrell Corporation OLD
$7K
ISRGIntuitive Surgical Inc
$1K
PreviousPage 9 of 9